BDBM506413 BDBM506508::US11045457, Example 13

SMILES C[C@@H]1CN(C)CC[C@H]1NC(=O)C(C)(C)COc1ncccc1OC(F)(F)F

InChI Key InChIKey=IHRBYCRDSUMVII-CHWSQXEVSA-N

Data  4 IC50  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 506413   

TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506413(BDBM506508 | US11045457, Example 13)
Affinity DataEC50:  3.98nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506413(BDBM506508 | US11045457, Example 13)
Affinity DataIC50:  31.6nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 1(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506413(BDBM506508 | US11045457, Example 13)
Affinity DataIC50:  2.00E+4nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR1 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506413(BDBM506508 | US11045457, Example 13)
Affinity DataEC50:  158nMAssay Description:This cell-based assay measures the ability of compounds to inhibit forskolin stimulated cAMP in CHO-K1 cells overexpressing SSTR4. CHO-K1 cells overe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506413(BDBM506508 | US11045457, Example 13)
Affinity DataIC50:  794nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR4 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSomatostatin receptor type 1(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM506413(BDBM506508 | US11045457, Example 13)
Affinity DataIC50:  5.01E+3nMAssay Description:This membrane-based assay measures the ability of compounds to competitively inhibit binding of I-125 labeled somatostatin to SSTR1 in membranes from...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent